-
My Account
In App
My Account
BSE Live
Dec 27, 11:22Prev. Close
2.30
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Key Financial Ratios of Standard Medical Pharmaceuticals (in Rs. Cr.) | Mar 17 | Mar 16 | Mar 15 | Mar 14 | Mar 13 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 0.00 | -0.01 | -1.38 | -0.11 | -0.10 | |
| Diluted EPS (Rs.) | 0.00 | -0.01 | -1.38 | -0.11 | -0.10 | |
| Cash EPS (Rs.) | 0.00 | -0.01 | -1.38 | -0.11 | -0.10 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | -16.30 | -16.30 | -16.38 | -15.00 | -14.89 | |
| Book Value [InclRevalReserve]/Share (Rs.) | -16.30 | -16.30 | -16.38 | -15.00 | -14.89 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PBDIT/Share (Rs.) | 0.00 | -0.01 | -0.11 | -0.11 | -0.10 | |
| PBIT/Share (Rs.) | 0.00 | -0.01 | -0.11 | -0.11 | -0.11 | |
| PBT/Share (Rs.) | 0.00 | -0.01 | -1.38 | -0.11 | -0.11 | |
| Net Profit/Share (Rs.) | 0.00 | -0.01 | -1.38 | -0.11 | -0.11 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PBIT Margin (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PBT Margin (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Profit Margin (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Return on Networth / Equity (%) | 0.00 | 0.04 | 8.44 | 0.73 | 0.70 | |
| Return on Capital Employed (%) | 0.65 | 4.50 | 881.04 | -5.13 | -5.96 | |
| Return on Assets (%) | -13.72 | -74.54 | -11,898.47 | -4.29 | -4.07 | |
| Total Debt/Equity (X) | -0.99 | -0.99 | -0.99 | -1.14 | -1.13 | |
| Asset Turnover Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 0.00 | 0.01 | 0.02 | 0.03 | 0.02 | |
| Quick Ratio (X) | 0.00 | 0.01 | 0.02 | 0.03 | 0.02 | |
| Inventory Turnover Ratio (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EV/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EV/EBITDA (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/Net Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Yield | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
